Related references
Note: Only part of the references are listed.Hepatocellular carcinoma recurrence after direct-acting antiviral therapy: an individual patient data meta-analysis
Victor Sapena et al.
GUT (2022)
BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update
Maria Reig et al.
JOURNAL OF HEPATOLOGY (2022)
Emerging from the screening of 57 million citizens and treating 4 million patients: future strategies to eliminate hepatitis C from Egypt
Gamal Esmat et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2020)
Follow-up after radiological intervention in oncology: ECIO-ESOI evidence and consensus-based recommendations for clinical practice
Monique Maas et al.
INSIGHTS INTO IMAGING (2020)
Predictors of 5 year survival rate in hepatocellular carcinoma patients
Arash Sarveazad et al.
JOURNAL OF RESEARCH IN MEDICAL SCIENCES (2019)
Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases
Jorge A. Marrero et al.
HEPATOLOGY (2018)
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
Peter R. Galle et al.
JOURNAL OF HEPATOLOGY (2018)
Increased recurrence rates of hepatocellular carcinoma after DAA therapy in a hepatitis C-infected Egyptian cohort: A comparative analysis
M. El Kassas et al.
JOURNAL OF VIRAL HEPATITIS (2018)
Metabolic disorders across hepatocellular carcinoma in Italy
Filomena Morisco et al.
LIVER INTERNATIONAL (2018)
Determinants of survival following hepatocellular carcinoma in Egyptian patients with untreated chronic HCV infection in the pre-DAA era
Reem Waziry et al.
ARAB JOURNAL OF GASTROENTEROLOGY (2018)
The prevalence of hepatitis C virus infection in Egypt 2015: implications for future policy on prevention and treatment
Amr Kandeel et al.
LIVER INTERNATIONAL (2017)
Prognostic factors and predictors of sorafenib benefit in patients with hepatocellular carcinoma: Analysis of two phase III studies
Jordi Bruix et al.
JOURNAL OF HEPATOLOGY (2017)
National treatment programme of hepatitis C in Egypt: Hepatitis C virus model of care
W. El-Akel et al.
JOURNAL OF VIRAL HEPATITIS (2017)
Race/Ethnicity-Specific Disparities in Cancer Incidence, Burden of Disease, and Overall Survival Among Patients With Hepatocellular Carcinoma in the United States
John Ha et al.
CANCER (2016)
Evidence-Based Diagnosis, Staging, and Treatment of Patients With Hepatocellular Carcinoma
Jordi Bruix et al.
GASTROENTEROLOGY (2016)
Moving Beyond the Hazard Ratio in Quantifying the Between-Group Difference in Survival Analysis
Hajime Uno et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Comparing Staging Systems for Predicting Prognosis and Survival in Patients with Hepatocellular Carcinoma in Egypt
Asmaa Ibrahim Gomaa et al.
PLOS ONE (2014)
Restricted mean survival time: an alternative to the hazard ratio for the design and analysis of randomized trials with a time-to-event outcome
Patrick Royston et al.
BMC MEDICAL RESEARCH METHODOLOGY (2013)
A Comparison of Prognosis between Patients with Hepatitis B and C Virus-related Hepatocellular Carcinoma Undergoing Resection Surgery
Wei-Yu Kao et al.
WORLD JOURNAL OF SURGERY (2011)
Race, Ethnicity, and Socioeconomic Status Influence the Survival of Patients With Hepatocellular Carcinoma in the United States
Avo Artinyan et al.
CANCER (2010)
Further development of flexible parametric models for survival analysis
Paul C. Lambert et al.
STATA JOURNAL (2009)
Changing pattern of hepatitis C virus spread in rural areas of Egypt
N Arafa et al.
JOURNAL OF HEPATOLOGY (2005)
Prognostic factors for survival in patients with early-intermediate hepatocellular carcinoma undergoing nonsurgical therapy: comparison of Okuda, CLIP, and BCLC staging systems in a single Italian centre
A Grieco et al.
GUT (2005)
The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt
C Frank et al.
LANCET (2000)
Share Paper
